Cargando…
Corrigendum to “A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer” [Redox Biol. 54 (2022) 102358]
Autores principales: | Jiang, Chang, Ward, Nathan P., Prieto-Farigua, Nicolas, Kang, Yun Pyo, Thalakola, Anish, Teng, Mingxiang, DeNicola, Gina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287741/ https://www.ncbi.nlm.nih.gov/pubmed/35794066 http://dx.doi.org/10.1016/j.redox.2022.102393 |
Ejemplares similares
-
A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
por: Jiang, Chang, et al.
Publicado: (2022) -
Corrigendum to “Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation” [Redox Biol. 53 (2022) 102337]
por: Bakalova, Rumiana, et al.
Publicado: (2022) -
Corrigendum to “Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway” [Redox Biol. 18 (2018) 124–137]
por: Zhao, Xiao-Juan, et al.
Publicado: (2019) -
Corrigendum to “NCF4 dependent intracellular reactive oxygen species regulate plasma cell formation” [Redox Biol 56 (2022) 102422]
por: He, Chang, et al.
Publicado: (2022) -
Corrigendum to “Identification of Frataxin as a regulator of ferroptosis” [Redox Biol. 32 (2020) 101483]
por: Du, Jing, et al.
Publicado: (2023)